Quarterly report · Q2

Period2022-04-01 → 2022-09-30
Filed2022-11-21
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed

Amends S100PKO6.

Key figures · 61
MetricValuePeriodScopeSource row
Revenue¥417.1bn2022-04-01 → 2022-09-30Cons.Revenue IFRS (5-year summary)
Revenue¥224.8bn2022-07-01 → 2022-09-30dCons.Revenue IFRS (5-year summary)
Revenue¥750.1bn2021-04-01 → 2022-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥360.1bn2021-04-01 → 2021-09-30Cons.Revenue IFRS (5-year summary)
Revenue¥193.3bn2021-07-01 → 2021-09-30dCons.Revenue IFRS (5-year summary)
Operating income¥93.6bn2022-04-01 → 2022-09-30Cons.Operating profit loss IFRS
Operating income¥49.1bn2022-07-01 → 2022-09-30dCons.Operating profit loss IFRS
Operating income¥70.7bn2021-04-01 → 2021-09-30Cons.Operating profit loss IFRS
Operating income¥44.7bn2021-07-01 → 2021-09-30dCons.Operating profit loss IFRS
Profit before tax¥89.3bn2022-04-01 → 2022-09-30Cons.Profit loss before tax IFRS
Profit before tax¥47.3bn2022-07-01 → 2022-09-30dCons.Profit loss before tax IFRS
Profit before tax¥141.7bn2021-04-01 → 2022-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥68.4bn2021-04-01 → 2021-09-30Cons.Profit loss before tax IFRS
Profit before tax¥43.0bn2021-07-01 → 2021-09-30dCons.Profit loss before tax IFRS
Net income (owners)¥66.8bn2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥42.0bn2022-07-01 → 2022-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥115.7bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥62.4bn2021-04-01 → 2021-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥43.7bn2021-07-01 → 2021-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income¥66.9bn2022-04-01 → 2022-09-30Cons.Profit loss IFRS
Net income¥42.0bn2022-07-01 → 2022-09-30dCons.Profit loss IFRS
Net income¥62.5bn2021-04-01 → 2021-09-30Cons.Profit loss IFRS
Net income¥43.8bn2021-07-01 → 2021-09-30dCons.Profit loss IFRS
Total assets¥1.49Tat 2022-09-30Cons.Assets IFRS
Total assets¥1.36Tat 2022-03-31Cons.Assets IFRS
Total assets¥1.19Tat 2021-09-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥842.0bnat 2022-09-30Cons.Liabilities IFRS
Total liabilities¥846.6bnat 2022-03-31Cons.Liabilities IFRS
Net assets / equity¥644.1bnat 2022-09-30Cons.Equity IFRS
Net assets / equity¥511.4bnat 2022-03-31Cons.Equity IFRS
Net assets / equity¥447.2bnat 2021-09-30Cons.Equity IFRS
Net assets / equity¥395.5bnat 2021-03-31dCons.Equity IFRS
Equity (owners)¥643.0bnat 2022-09-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥510.2bnat 2022-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥446.1bnat 2021-09-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥255.8bnat 2022-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥297.4bnat 2022-09-30Cons.Cash and cash equivalents IFRS (5-year summary)
Cash & equivalents¥302.6bnat 2022-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥193.4bnat 2021-09-30Cons.Cash and cash equivalents IFRS (5-year summary)
Operating cash flow¥6.3bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥169.7bn2021-04-01 → 2022-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥68.8bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥15.7bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥71.0bn2021-04-01 → 2022-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥50.5bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥35.5bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥40.7bn2021-04-01 → 2022-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥44.1bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥52.52022-04-01 → 2022-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥32.972022-07-01 → 2022-09-30dCons.Basic earnings loss per share IFRS
EPS (basic)¥90.222021-04-01 → 2022-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥48.532021-04-01 → 2021-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥342021-07-01 → 2021-09-30dCons.Basic earnings loss per share IFRS
EPS (diluted)¥52.452022-04-01 → 2022-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥32.932022-07-01 → 2022-09-30dCons.Diluted earnings loss per share IFRS
EPS (diluted)¥90.172021-04-01 → 2022-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥48.512021-04-01 → 2021-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥33.982021-07-01 → 2021-09-30dCons.Diluted earnings loss per share IFRS
Equity ratio43.3%at 2022-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio37.6%at 2022-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio37.6%at 2021-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 10
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-09-30−¥4.3bn
jpcrp040300-q2r_E02272-000Endoscopic Solutionsreportable segmentsegment profit2022-04-01 → 2022-09-30¥68.9bn
jpcrp040300-q2r_E02272-000Otherreportable segmentsegment profit2022-04-01 → 2022-09-30−¥788m
jpcrp040300-q2r_E02272-000Therapeutic Solutionsreportable segmentsegment profit2022-04-01 → 2022-09-30¥29.8bn
—segment totalsegment profit2022-04-01 → 2022-09-30¥97.9bn
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-09-30−¥20.1bn
jpcrp040300-q2r_E02272-000Endoscopic Solutionsreportable segmentsegment profit2021-04-01 → 2021-09-30¥61.6bn
jpcrp040300-q2r_E02272-000Otherreportable segmentsegment profit2021-04-01 → 2021-09-30−¥1.1bn
jpcrp040300-q2r_E02272-000Therapeutic Solutionsreportable segmentsegment profit2021-04-01 → 2021-09-30¥30.3bn
—segment totalsegment profit2021-04-01 → 2021-09-30¥90.8bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 766
ItemContextValueUnit
Cash and cash equivalents IFRS (5-year summary)Prior1YearInstant302572000000JPY
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember1285892000
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember1285892000
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant1285892000
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant1285892000
Number of shares heldCurrentQuarterInstant_No1MajorShareholdersMember238194600
Shareholding ratioCurrentQuarterInstant_No1MajorShareholdersMember0.1871
Number of shares heldCurrentQuarterInstant_No2MajorShareholdersMember83203500
Shareholding ratioCurrentQuarterInstant_No2MajorShareholdersMember0.0654
Number of shares heldCurrentQuarterInstant_No3MajorShareholdersMember74905417
Shareholding ratioCurrentQuarterInstant_No3MajorShareholdersMember0.0588
Number of shares heldCurrentQuarterInstant_No4MajorShareholdersMember50543573
Shareholding ratioCurrentQuarterInstant_No4MajorShareholdersMember0.0397
Number of shares heldCurrentQuarterInstant_No5MajorShareholdersMember39509300
Shareholding ratioCurrentQuarterInstant_No5MajorShareholdersMember0.0310
Number of shares heldCurrentQuarterInstant_No6MajorShareholdersMember30522344
Shareholding ratioCurrentQuarterInstant_No6MajorShareholdersMember0.0240
Number of shares heldCurrentQuarterInstant_No7MajorShareholdersMember29462949
Shareholding ratioCurrentQuarterInstant_No7MajorShareholdersMember0.0231
Number of shares heldCurrentQuarterInstant_No8MajorShareholdersMember27196784
Shareholding ratioCurrentQuarterInstant_No8MajorShareholdersMember0.0214
Number of shares heldCurrentQuarterInstant_No9MajorShareholdersMember21258572
Shareholding ratioCurrentQuarterInstant_No9MajorShareholdersMember0.0167
Number of shares heldCurrentQuarterInstant_No10MajorShareholdersMember20758412
Shareholding ratioCurrentQuarterInstant_No10MajorShareholdersMember0.0163
Number of shares heldCurrentQuarterInstant615555451
Shareholding ratioCurrentQuarterInstant0.4835
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithNoVotingRightsMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of voting rights issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember12740900
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember1272982700
Number of voting rights issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember12729827
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember168400
Number of shares issued shares voting rightsCurrentQuarterInstant1285892000
Number of voting rights issued shares voting rightsCurrentQuarterInstant12729827
Number of shares held in own name treasury shares etcCurrentQuarterInstant_Row1Member12740900
Number of shares held in others names treasury shares etcCurrentQuarterInstant_Row1Member-
Total number of shares held treasury shares etcCurrentQuarterInstant_Row1Member12740900
Shareholding ratio treasury shares etcCurrentQuarterInstant_Row1Member0.0099
Number of shares held in own name treasury shares etcCurrentQuarterInstant12740900
Number of shares held in others names treasury shares etcCurrentQuarterInstant-
Total number of shares held treasury shares etcCurrentQuarterInstant12740900
Shareholding ratio treasury shares etcCurrentQuarterInstant0.0099
Cash and cash equivalents IFRSPrior1YearInstant302572000000JPY
Cash and cash equivalents IFRSCurrentQuarterInstant255765000000JPY
Trade and other receivables ca IFRSPrior1YearInstant178428000000JPY
Trade and other receivables ca IFRSCurrentQuarterInstant187461000000JPY
Other financial assets ca IFRSPrior1YearInstant10269000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-09-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-07-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-07-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass